IQVIA Holdings | IQV - Cash And Equivalent


IQVIA Holdings reported $1.98B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Accenture USD 9.65B 1.83B Sep/2025
Agilent USD 1.79B 254M Sep/2025
Bruker USD 293.1M 201.1M Sep/2025
Cardinal Health USD 2.78B 1.82B Dec/2025
Celltrion KRW 29.65B 799.42B Jun/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Cigna USD 6.02B 1.7B Sep/2025
Cognizant Technology Solutions USD 1.9B 440M Dec/2025
Cspc Pharmaceutical CNY 7.57B 793.73M Jun/2025
CVS Health USD 9.1B 2.69B Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Dentsply International USD 363M 4M Sep/2025
Dianthus Therapeutics USD 55.98M 42.75M Sep/2025
Divis Laboratories Ltd INR 4.15B 31.87B Mar/2025
Elevance Health USD 9.49B 778M Dec/2025
Hologic USD 2.17B 208.5M Dec/2025
Humana USD 5.39B 1.35B Sep/2025
IBM USD 13.59B 2.02B Dec/2025
Illumina USD 1.42B 368M Dec/2025
Infosys INR 3.59B 383M Sep/2025
Kangmei Pharma CNY 1.18B 278M Sep/2025
Knight Therapeutics CAD 77.82M 34.34M Jun/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Laboratory Of America USD 598.1M 49.2M Sep/2025
Malin Corporation EUR 62.1M 26.4M Dec/2024
McKesson USD 2.96B 1.05B Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Organigram Holdings CAD 28.2M 7.68M Sep/2025
Pharma Mar EUR 21.59M 38.7M Jun/2025
Publicis EUR 2.21B 1.44B Jun/2025
Qiagen NV USD 1.36B 621.78M Sep/2025
Quest Diagnostics USD 432M 113M Sep/2025
Revvity USD 931.39M 60.46M Sep/2025
Sartorius EUR 389.9M 429.1M Sep/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Tilray USD 264.83M 43.16M Jun/2025
UnitedHealth USD 28.12B 2.49B Dec/2025
Veeva Systems USD 1.66B 270.29M Sep/2025
Waters USD 459.12M 91.9M Sep/2025
Zz Pientze Pharmaceu CNY 1.77B 376.03M Jun/2025